Abbott/Perclose
This article was originally published in The Gray Sheet
Executive Summary
Stock swap acquisition of arterial access site closure device maker Perclose, valued at $644 mil., is completed, Abbott announces Nov. 19. The deal was announced in July (1"The Gray Sheet" July 12, p. 3)